Dow Up 0.12% Nasdaq Up 1.35%

Vertex Pharmaceuticals Incorporated (VRTX)

-NasdaqGS
104.77 2.42(2.36%) Oct 20, 4:00PM EDT
Prev Close:102.35
Open:102.51
Bid:82.56 x 100
Ask:120.00 x 500
1y Target Est:115.41
Beta:-0.97
Next Earnings Date:28-Oct-14VRTX Earnings announcement
Day's Range:101.85 - 105.00
52wk Range:58.06 - 116.88
Volume:1,178,616
Avg Vol (3m):1,647,480
Market Cap:24.94B
P/E (ttm):N/A
EPS (ttm):-2.03
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VRTXUp 2.36%24.94B
BMY83.82B
MRK155.91B
PTCT1.10B

Key Statistics

Forward P/E (1 yr):1,047.70
P/S (ttm):29.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.86
Quarterly EPS Est (Sep-14) :-0.63
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):-1.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback